Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup
Health-care companies rose, but not by as much as the broad market, as defensively minded traders rotated into the utilities sector.
Novavax, the pharmaceutical company that last year warned that falling sales of its Covid-19 vaccine could put it out of business, said it reached a $1.4 billion deal with French company Sanofi to commercialize its existing treatment and develop a new one.
Organogenesis Holdings shares rose after the company reported a narrower loss for the first quarter along with higher revenue.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
May 10, 2024 17:01 ET (21:01 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Best- and Worst-Performing Stocks of May 2024
-
3 Stocks to Buy and 3 Stocks to Sell in June
-
Markets Brief: Friday’s Job Report in Focus
-
These Stocks Are (Still) Powering the Bull Market
-
5 Undervalued Energy Stocks to Play the AI Data Center Demand Boom
-
After Earnings, Is Lowe’s Stock a Buy, Sell, or Fairly Valued?
-
5 Stocks With the Largest Fair Value Estimate Cuts After Q1 Earnings
-
10 Stocks With the Largest Fair Value Estimate Increases After Q1 Earnings
-
Manager: Nvidia Will Be Biggest Company in the World
-
The Best Utilities Stocks to Buy
-
3 Cheap Dividend Stocks to Buy Yielding 4% or More
-
After Earnings, Is Salesforce Stock a Buy, Sell, or Fairly Valued?
-
Broadcom: Raising Valuation Estimate as AI Becomes a Greater Driver of Growth
-
3 Dividend Stocks for June 2024
-
After Earnings, Is Alibaba Stock a Buy, Sell, or Fairly Valued?
-
MongoDB Earnings: Slashing Valuation as Execution and Macro to Blame for Lower Guidance